Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513

Clinical trial NCT03507569 · COMPLETED

Trial details

NCT number: NCT03507569
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2018-04-24
Primary completion: 2018-06-22
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.